Reza Tabrizchi. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Adrenergic beta-Antagonists/administration & dosageAdrenergic beta-Antagonists/therapeutic useAngiotensin-Converting Enzyme Inhibitors/therapeutic useCoronary Artery Disease/drug therapyCoronary Artery Disease/epidemiologyDose-Response Relationship, DrugHeart Failure/drug therapyHeart Failure/epidemiologyHumansMetoprolol/administration & dosageMetoprolol/therapeutic useQuality of LifeUnited States/epidemiologyVentricular Dysfunction, Left/drug therapyVentricular Dysfunction, Left/epidemiology
Substances： See more » Adrenergic beta-AntagonistsAngiotensin-Converting Enzyme InhibitorsMetoprolol
Year: 2003 PMID： 15030275 DOI： 10.1586/14779072.1.2.157
Source DB: PubMed Journal: Expert Rev Cardiovasc Ther ISSN： 1477-9072